Pharma sector continues to thrive, driven by price-led expansion
The Indian pharmaceutical market demonstrated robust growth in April 2025, achieving a 7.8% annual increase, fueled by price adjustments and new product introductions. Sales reached Rs 19,711 crore, with cardiac, neuro/CNS, and anti-neoplastics segments significantly contributing to this expansion. Despite modest volume growth, effective pricing strategies and demand in chronic and acute care drove the industry’s success.🕒 1 min read
The Indian pharmaceutical market demonstrated robust growth in April 2025, achieving a 7.8% annual increase, fueled by price adjustments and new product introductions. Sales reached Rs 19,711 crore, with cardiac, neuro/CNS, and anti-neoplastics segments significantly contributing to this expansion. Despite modest volume growth, effective pricing strategies and demand in chronic and acute care drove the industry’s success.Continue Reading
-
‘Unlawful’: Bangladesh HC questions BCB over female crickters’ safety
- Sunil Gavaskar Comes Up With Bold Idea For IPL, Sends Stunning Message To BCCI
- FM Sitharaman rules out roadmap for PSU bank mergers, panel to review sector reforms
- Honduras Planning To Buy Ukrainian Drones To Fight Drug Trade
- KEAM 2025 Rank List Released, Direct Link Here
-
“When I Founded RCB…”: Vijay Mallya’s Unmissable Post On Team Winning IPL
- UGC NET June 2026: Admit Card Details, Marking Scheme, Exam Day Rules
-
BJP Sends Defamation Notice To Bhagwant Mann Over Punjab Blasts’ Allegations
- CBSE Class 10 English Exam 2026: Essential Last-Minute Tips + Sample Paper Download
-
India’s Asia Cup 2025 Squad Announcement Live Updates: Shubman Gill Puzzle Solved, BCCI Says This On Snubbing 2 Stars With 1160+ Runs In IPL
